Critical issues in prevention and control of rheumatic fever and rheumatic heart disease

    Research output: Chapter in Book/Report/Conference proceedingChapterResearchpeer-review

    Abstract

    The evidence base for public health and therapeutic interventions to prevent and control acute rheumatic fever (ARF) and rheumatic heart disease (RHD) still has some big gaps. Resolving critical issues in the pathogenesis of ARF should accelerate vaccine development and provide reassurances about vaccine safety. The basis of the genetic restriction of ARF predisposition and of the "immunogenic" determinants within group A streptococci (GAS) are critical to define. Also important is whether other bacteria such as groups C and G streptococci can be rheumatogenic and whether skin streptococci can cause ARF, either directly or via secondary throat colonization. Benzathine penicillin remains the mainstay of secondary prevention by preventing recurrent ARF and progression of RHD. However, there remain major issues of quality, supply, dosing, optimal timing of dosing and how best to incorporate secondary prophylaxis into primary care with either vertical or horizontal programs. Alternative secondary prophylaxis regimens remain to be developed. � 2006.
    Original languageEnglish
    Title of host publicationStreptococci
    Subtitle of host publicationNew Insights into an Old Enemy
    EditorsKS Sriprakash
    Place of PublicationAmsterdam
    PublisherElsevier
    Pages281-284
    Number of pages4
    ISBN (Print)444522050
    Publication statusPublished - 2006

    Fingerprint

    Rheumatic Heart Disease
    Rheumatic Fever
    Streptococcus
    Vaccines
    Penicillin G Benzathine
    Secondary Prevention
    Pharynx
    Primary Health Care
    Public Health
    Bacteria
    Safety
    Skin

    Cite this

    Currie, B. (2006). Critical issues in prevention and control of rheumatic fever and rheumatic heart disease. In KS. Sriprakash (Ed.), Streptococci: New Insights into an Old Enemy (pp. 281-284). Amsterdam: Elsevier.
    Currie, Bart. / Critical issues in prevention and control of rheumatic fever and rheumatic heart disease. Streptococci: New Insights into an Old Enemy. editor / KS Sriprakash. Amsterdam : Elsevier, 2006. pp. 281-284
    @inbook{89d310361474498e8ac59902edfb16e3,
    title = "Critical issues in prevention and control of rheumatic fever and rheumatic heart disease",
    abstract = "The evidence base for public health and therapeutic interventions to prevent and control acute rheumatic fever (ARF) and rheumatic heart disease (RHD) still has some big gaps. Resolving critical issues in the pathogenesis of ARF should accelerate vaccine development and provide reassurances about vaccine safety. The basis of the genetic restriction of ARF predisposition and of the {"}immunogenic{"} determinants within group A streptococci (GAS) are critical to define. Also important is whether other bacteria such as groups C and G streptococci can be rheumatogenic and whether skin streptococci can cause ARF, either directly or via secondary throat colonization. Benzathine penicillin remains the mainstay of secondary prevention by preventing recurrent ARF and progression of RHD. However, there remain major issues of quality, supply, dosing, optimal timing of dosing and how best to incorporate secondary prophylaxis into primary care with either vertical or horizontal programs. Alternative secondary prophylaxis regimens remain to be developed. � 2006.",
    author = "Bart Currie",
    year = "2006",
    language = "English",
    isbn = "444522050",
    pages = "281--284",
    editor = "KS Sriprakash",
    booktitle = "Streptococci",
    publisher = "Elsevier",
    address = "United Kingdom",

    }

    Currie, B 2006, Critical issues in prevention and control of rheumatic fever and rheumatic heart disease. in KS Sriprakash (ed.), Streptococci: New Insights into an Old Enemy. Elsevier, Amsterdam, pp. 281-284.

    Critical issues in prevention and control of rheumatic fever and rheumatic heart disease. / Currie, Bart.

    Streptococci: New Insights into an Old Enemy. ed. / KS Sriprakash. Amsterdam : Elsevier, 2006. p. 281-284.

    Research output: Chapter in Book/Report/Conference proceedingChapterResearchpeer-review

    TY - CHAP

    T1 - Critical issues in prevention and control of rheumatic fever and rheumatic heart disease

    AU - Currie, Bart

    PY - 2006

    Y1 - 2006

    N2 - The evidence base for public health and therapeutic interventions to prevent and control acute rheumatic fever (ARF) and rheumatic heart disease (RHD) still has some big gaps. Resolving critical issues in the pathogenesis of ARF should accelerate vaccine development and provide reassurances about vaccine safety. The basis of the genetic restriction of ARF predisposition and of the "immunogenic" determinants within group A streptococci (GAS) are critical to define. Also important is whether other bacteria such as groups C and G streptococci can be rheumatogenic and whether skin streptococci can cause ARF, either directly or via secondary throat colonization. Benzathine penicillin remains the mainstay of secondary prevention by preventing recurrent ARF and progression of RHD. However, there remain major issues of quality, supply, dosing, optimal timing of dosing and how best to incorporate secondary prophylaxis into primary care with either vertical or horizontal programs. Alternative secondary prophylaxis regimens remain to be developed. � 2006.

    AB - The evidence base for public health and therapeutic interventions to prevent and control acute rheumatic fever (ARF) and rheumatic heart disease (RHD) still has some big gaps. Resolving critical issues in the pathogenesis of ARF should accelerate vaccine development and provide reassurances about vaccine safety. The basis of the genetic restriction of ARF predisposition and of the "immunogenic" determinants within group A streptococci (GAS) are critical to define. Also important is whether other bacteria such as groups C and G streptococci can be rheumatogenic and whether skin streptococci can cause ARF, either directly or via secondary throat colonization. Benzathine penicillin remains the mainstay of secondary prevention by preventing recurrent ARF and progression of RHD. However, there remain major issues of quality, supply, dosing, optimal timing of dosing and how best to incorporate secondary prophylaxis into primary care with either vertical or horizontal programs. Alternative secondary prophylaxis regimens remain to be developed. � 2006.

    M3 - Chapter

    SN - 444522050

    SP - 281

    EP - 284

    BT - Streptococci

    A2 - Sriprakash, KS

    PB - Elsevier

    CY - Amsterdam

    ER -

    Currie B. Critical issues in prevention and control of rheumatic fever and rheumatic heart disease. In Sriprakash KS, editor, Streptococci: New Insights into an Old Enemy. Amsterdam: Elsevier. 2006. p. 281-284